[A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia]

Acta Psiquiatr Psicol Am Lat. 1983 Dec;29(4):261-6.
[Article in Portuguese]

Abstract

Appropriate manipulation of dopaminergic systems, that probably contribute to tardive dyskinesia, may bring about a reduction in its intensity. In this study various, increasing doses of L-dopa, which is converted to dopamine in the CNS, was administered over the relatively long period of time of one month, in double-blind conditions, to psychiatric patients with stabilized psychotic symptoms, with tardive dyskinesia. With the one gram daily dose group, there was a reduction of the intensity of the involuntary movements, when compared to that of the patients who received placebo.

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • Clinical Trials as Topic
  • Double-Blind Method
  • Dyskinesia, Drug-Induced / drug therapy*
  • Female
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / therapeutic use*
  • Male
  • Placebos
  • Psychotic Disorders / drug therapy
  • Psychotic Disorders / physiopathology*

Substances

  • Placebos
  • Levodopa